Premier Fund Managers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Buy
2,729
+671
+33% +$64K 0.02% 128
2025
Q4
$171K Hold
2,058
0.01% 150
2025
Q3
$176K Sell
2,058
-4,875
-70% -$435K 0.01% 170
2025
Q2
$573K Buy
6,933
+918
+15% +$76.7K 0.02% 137
2025
Q1
$500K Hold
6,015
0.02% 153
2024
Q4
$560K Hold
6,015
0.02% 164
2024
Q3
$551K Hold
6,015
0.02% 156
2024
Q2
$495K Buy
+6,015
New +$442K 0.02% 152

Other funds holding LMAT

Premier Fund Managers's LMAT Position: Q1 2026 in Review

Premier Fund Managers increased its LeMaitre Vascular (LMAT) stake by 33% in Q1 2026, buying an estimated $64K and bringing the position to 2,729 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #128.

Premier Fund Managers first reported a position in LMAT in Q2 2024 and has held it in 8 quarters since. The position peaked at $573K in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Premier Fund Managers held 2,729 shares of LeMaitre Vascular worth $292K as of Q1 2026.
  • Premier Fund Managers bought 671 LeMaitre Vascular shares in Q1 2026, an estimated $64K.
  • LeMaitre Vascular made up 0.02% of Premier Fund Managers's portfolio in Q1 2026, its #128 holding.
  • Premier Fund Managers first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 8 quarters since.
  • Premier Fund Managers's LeMaitre Vascular position peaked at $573K in Q2 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Premier Fund Managers's 13F filing for Q1 2026, filed 14 May 2026.